Arrowhead Pharmaceuticals所有资讯

Arrowhead Pharmaceuticals | 144：拟议出售证券

05/03 02:44

Arrowhead Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(10.01%)

04/11 02:08

Arrowhead Pharmaceuticals | 4：持股变动声明-高管 Hamilton James C

04/04 06:09

Arrowhead Pharmaceuticals | 144：拟议出售证券

04/02 04:33

Arrowhead Pharmaceuticals | 4：持股变动声明-董事 Lu Hongbo

03/21 07:08

Arrowhead Pharmaceuticals | 8-K：重大事件

03/20 04:42

Arrowhead Pharmaceuticals | 3：首次持股声明-董事 Lu Hongbo

03/19 07:01

Arrowhead Pharmaceuticals | 8-K/A：重大事件(修正)

03/19 03:37

Arrowhead Pharmaceuticals | 4：持股变动声明-高管 Myszkowski Kenneth Allen

03/09 06:57

Arrowhead Pharmaceuticals | 144：拟议出售证券

03/07 06:35

Arrowhead Pharmaceuticals | S-8：员工福利计划证券登记

02/29 11:29

Arrowhead Pharmaceuticals | DEFA14A：其他

02/28 06:15

Arrowhead Pharmaceuticals | 8-K：重大事件

02/23 03:40

Arrowhead Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(9.93%)

02/14 06:00

Arrowhead Pharmaceuticals | 10-Q：季度报表

02/07 05:19

Arrowhead Pharmaceuticals | 8-K：Arrowhead Pharmicals公布2024财年第一季度业绩

02/07 05:08

Arrowhead Pharmaceuticals | 4：持股变动声明-高管 Anzalone Christopher Richard

02/03 06:27

Arrowhead Pharmaceuticals | 144：拟议出售证券

02/01 06:03

Arrowhead Pharmaceuticals | ARS：年度报告

01/30 03:48

Arrowhead Pharmaceuticals | DEF 14A：股东委托书决议

01/27 06:32